General Information
Version
CAT 1041 - Sulindac
Revision date
2023-06-13
Product name
Sulindac
Substance name
C20 H17 F O3 S 356.41
Chemical name
Sulindac
CAS No.
38194-50-2
1.2.1 Relevant identified uses
Laboratory use
supplier name
British Pharmacopoeia Commission
Emergency telephone
+44 (0)20 3080 6561
Icons in SDS
Company Information
company name
British Pharmacopoeia Commission
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H317, H334, H361
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
Sulindac
Signal word
Danger
Hazard statements
H301 - Toxic if swallowed H317 - May cause an allergic skin reaction H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled H361 - Suspected of damaging fertility or the unborn child
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray P280 - Wear protective gloves/protective clothing/eye protection/face protection P301 + P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor
2.3 Other hazards
This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity - Oral Category 3 - (H301) Respiratory sensitisation Category 1 - (H334) Skin sensitisation Category 1 - (H317) Reproductive toxicity Category 2 - (H361)
